Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

Knowridge Reports on Plante Study of ‘Stiff-Heart’ Patients and Beta-Blockers

July 27, 2022 by Lucy Gardner Carson

(JULY 27, 2022) A recent study by Timothy Plante, M.D., assistant professor of medicine, and colleagues found that so-called stiff-heart heart failure accounts for about half of all cases; in addition, most stiff-heart patients take beta-blocker medications despite unclear benefits from their regular use, according to Knowridge Science Report.

Timothy Plante, M.D., assistant professor of medicine

(JULY 27, 2022) A recent study by Timothy Plante, M.D., assistant professor of medicine, and colleagues found that so-called stiff-heart heart failure (in stiff-heart heart failure, the heart is less able to relax and fill with blood) accounts for about half of all cases; in addition, most stiff-heart patients take beta-blocker medications despite unclear benefits from their regular use, according to Knowridge Science Report.

Because beta-blockers save lives in “weak-heart” heart failure (in weak-heart heart failure, the heart muscle is unable to contract well), doctors assume they are also effective in stiff-heart heart failure — but the researchers found beta-blocker use to be a risk factor for hospitalizations for heart failure among these patients with stiff-heart heart failure. Beta-blocker use was linked to a 74 percent higher risk of heart failure hospitalizations among participants with heart failure and a normal pump function.

Despite their common use, the researchers note that beta-blocker use in stiff-heart heart failure has not been sufficiently studied.

Read full story at Knowridge Science Report